BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17660955)

  • 21. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
    Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
    Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
    Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
    Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
    Nakuci E; Mahner S; Direnzo J; ElShamy WM
    Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
    Agadir A; Shealy YF; Hill DL; Zhang X
    Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
    O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
    Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
    van de Stolpe A; Slycke AJ; Reinders MO; Zomer AW; Goodenough S; Behl C; Seasholtz AF; van der Saag PT
    Mol Endocrinol; 2004 Dec; 18(12):2908-23. PubMed ID: 15345745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis.
    Mallano T; Palumbo-Zerr K; Zerr P; Ramming A; Zeller B; Beyer C; Dees C; Huang J; Hai T; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2016 Mar; 75(3):586-92. PubMed ID: 25589515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The function of heterodimeric AP-1 comprised of c-Jun and c-Fos in activin mediated Spemann organizer gene expression.
    Lee SY; Yoon J; Lee HS; Hwang YS; Cha SW; Jeong CH; Kim JI; Park JB; Lee JY; Kim S; Park MJ; Dong Z; Kim J
    PLoS One; 2011; 6(7):e21796. PubMed ID: 21829441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
    Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
    Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro.
    Shen Y; Wu Y; Lu Q; Zhang P; Ren M
    Tumour Biol; 2016 Jan; 37(1):455-62. PubMed ID: 26224478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
    Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH
    Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription.
    Jeffy BD; Hockings JK; Kemp MQ; Morgan SS; Hager JA; Beliakoff J; Whitesell LJ; Bowden GT; Romagnolo DF
    Neoplasia; 2005 Sep; 7(9):873-82. PubMed ID: 16229810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes.
    DeNardo DG; Kim HT; Hilsenbeck S; Cuba V; Tsimelzon A; Brown PH
    Mol Endocrinol; 2005 Feb; 19(2):362-78. PubMed ID: 15514030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERalpha and AP-1 interact in vivo with a specific sequence of the F promoter of the human ERalpha gene in osteoblasts.
    Lambertini E; Tavanti E; Torreggiani E; Penolazzi L; Gambari R; Piva R
    J Cell Physiol; 2008 Jul; 216(1):101-10. PubMed ID: 18247370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unliganded estrogen receptor α stimulates bone sialoprotein gene expression.
    Takai H; Matsumura H; Matsui S; Kim KM; Mezawa M; Nakayama Y; Ogata Y
    Gene; 2014 Apr; 539(1):50-7. PubMed ID: 24495337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
    Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
    PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JNK-Dependent cJun Phosphorylation Mitigates TGFβ- and EGF-Induced Pre-Malignant Breast Cancer Cell Invasion by Suppressing AP-1-Mediated Transcriptional Responses.
    Sundqvist A; Voytyuk O; Hamdi M; Popeijus HE; van der Burgt CB; Janssen J; Martens JWM; Moustakas A; Heldin CH; Ten Dijke P; van Dam H
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.